{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T11:10:34Z","timestamp":1683198634323},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"763","license":[{"start":{"date-parts":[[1989,5,1]],"date-time":"1989-05-01T00:00:00Z","timestamp":609984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1989,5,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>The complications and costs of chronic dialysis in 4 patients with renal failure due to multiple myeloma are presented. In three patients the paraprotein responded to chemotherapy though without recovery of renal function. These three patients are alive after 18, 16 and 15 months of dialysis, the other dying after 7 months. Hospital admissions ranged from 26 to 74 days per year with infections accounting for 54 to 87% of admission days, 62.5% of which occurred during the first three months of dialysis treatment, with an incidence of 2.4 to 6.9 admissions episodes per year.<\/jats:p>\n               <jats:p>An in-house audit of our chronic dialysis patients indicated that treatment of myeloma patients is 5-33% more expensive. The extra cost in such high risk patients is mostly due to the greater number and longer duration of hospital admissions for infection. The other extra costs (in decreasing value) of blood products, antibiotics and chemotherapy are relatively small in comparison to in-patient treatment.<\/jats:p>","DOI":"10.1136\/pgmj.65.763.302","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:05:27Z","timestamp":1230584727000},"page":"302-306","source":"Crossref","is-referenced-by-count":2,"title":["The cost of chronic dialysis in multiple myeloma"],"prefix":"10.1093","volume":"65","author":[{"given":"R A","family":"Coward","sequence":"first","affiliation":[{"name":"Department of Renal Medicine, Royal Preston Hospital , Sharoe Green Lane, Preston , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1989,5,1]]},"reference":[{"key":"ref_1","first-page":"206","article-title":"Severe renal failure in multiple myeloma","volume":"15","author":"Cosio, F.G.; Pence, T.V.; Shapiro, F.P.; Kjellistrand, C.M.","year":"1981","unstructured":"Cosio, F.G., Pence, T.V., Shapiro, F.P. & Kjellistrand, C.M. Severe renal failure in multiple myeloma. Clin Nephrol 1981, 15: 206-210.","journal-title":"Clin Nephrol"},{"key":"ref_2","first-page":"65","article-title":"Dialysis in the treatment of multiple","volume-title":"myeloma. Mayo Clin Proc 1980, 55","author":"Johnson, W.G.; Kyle, R.A.; Dahlburg, P.J.","unstructured":"Johnson, W.G., Kyle, R.A. & Dahlburg, P.J. Dialysis in the treatment of multiple myeloma. Mayo Clin Proc 1980, 55: 65-72."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/bmj.287.6405.1575","article-title":"Should patients with renal failure associated with myeloma be dialysed?","volume":"287","author":"Coward, R.A.; Mallick, N.P.; Delamore, I.W.","year":"1983","unstructured":"Coward, R.A., Mallick, N.P. & Delamore, I.W. Should patients with renal failure associated with myeloma be dialysed? Br Med J 1983, 287: 1575-1578.","journal-title":"Br Med J"},{"issue":"13","key":"ref_4","first-page":"282","article-title":"Immunosuppression and infection in multiple myeloma","volume":"1986","author":"Jacobson, D.R.; Zolla-Pazner, S.","unstructured":"Jacobson, D.R. & Zolla-Pazner, S. Immunosuppression and infection in multiple myeloma. Semin Oncol 1986, 13: 282-290.","journal-title":"Semin Oncol"},{"issue":"71","key":"ref_5","first-page":"935","article-title":"Influence of treatment and response status on infection risk in multiple myeloma","volume":"1981","author":"Perri, R.T.; Hebbel, R.P.; Oken, M.M.","unstructured":"Perri, R.T., Hebbel, R.P. & Oken, M.M. Influence of treatment and response status on infection risk in multiple myeloma. JAMA 1981, 71: 935-939.","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bmj.294.6585.1467","article-title":"Prediction of resources needed to achieve the national target for treatment of renal failure","volume":"294","author":"Wood, I.T.; Mallick, N.P.; Wing, A.J.","year":"1987","unstructured":"Wood, I.T., Mallick, N.P. & Wing, A.J. Prediction of resources needed to achieve the national target for treatment of renal failure. Br Med J 1987, 294: 1467-1470.","journal-title":"Br Med J"},{"issue":"291","key":"ref_7","first-page":"326","article-title":"Coronary artery by-pass grafting, an economic appraisal","volume":"1985","author":"Williams, A.","unstructured":"Williams, A. Coronary artery by-pass grafting, an economic appraisal. Br Med J 1985, 291: 326-329.","journal-title":"Br Med J"},{"issue":"1","key":"ref_8","first-page":"1","article-title":"Demography of dialysis and transplantation in Europe 1984","volume":"1986","author":"of E. D. T. A. Registry, Report","unstructured":"Report of E.D.T.A. Registry. Demography of dialysis and transplantation in Europe 1984. Nephrol Dial Transplant 1986, 1: 1-8.","journal-title":"Nephrol Dial Transplant"},{"issue":"42","key":"ref_9","first-page":"823","article-title":"Treatment comparisons in the third MRC myelomatosis trial","volume":"1980","author":"Council, Medical Research","unstructured":"Medical Research Council. Treatment comparisons in the third MRC myelomatosis trial. Br J Cancer 1980,42: 823-830.","journal-title":"Br J Cancer"},{"key":"ref_10","article-title":"toxicity and efficacy in patients with multiple myeloma and other lymphoid malignancies. Haematol Oncol in press","author":"Anderson, H.Scarffe; H., J.; Lambert, M.","unstructured":"Anderson, H. Scarffe, J.H., Lambert, M. et al. VAD chemotherapy, toxicity and efficacy in patients with multiple myeloma and other lymphoid malignancies. Haematol Oncol in press."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198405243102104","article-title":"Effective treatment of advanced multiple myeloma refactory to alkylating agents","volume":"310","author":"Barlogie, B.; Smith, L.; Alexanian, R.","year":"1984","unstructured":"Barlogie, B., Smith, L. & Alexanian, R. Effective treatment of advanced multiple myeloma refactory to alkylating agents. N Engl J Med 1984, 310: 1353-1356.","journal-title":"N Engl J Med"},{"key":"ref_12","first-page":"29","article-title":"Multiple myeloma - A review of 869 cases","volume-title":"Mayo Clin Proc 1975","volume":"50","author":"Kyle, R.A.","unstructured":"Kyle, R.A. Multiple myeloma - A review of 869 cases. Mayo Clin Proc 1975, 50: 29-40."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/bjc.1980.330","article-title":"Medical Research Council working party on leukaemia in adults. Prognostic features in the third MRC myelomatosis trial","volume":"42","year":"1980","unstructured":"Medical Research Council working party on leukaemia in adults. Prognostic features in the third MRC myelomatosis trial. Br J Cancer 1980, 42: 831-840.","journal-title":"Br J Cancer"},{"issue":"288","key":"ref_14","first-page":"1411","article-title":"Medical Research Council working party on leukaemia in adults. Analysis and management of renal failure in the fourth MRC myelomatosis trial","volume":"1984","unstructured":"Medical Research Council working party on leukaemia in adults. Analysis and management of renal failure in the fourth MRC myelomatosis trial. Br MedJ 1984,288: 1411-1416.","journal-title":"Br MedJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005792-198703000-00004","article-title":"Multiple myeloma and severe renal failure: a clinico-pathological study of outcome and prognosis in 34 patients","volume":"66","author":"Rota, S.; Mangenot, B.; Baudouim, B.","year":"1987","unstructured":"Rota, S., Mangenot, B., Baudouim, B. et al. Multiple myeloma and severe renal failure: a clinico-pathological study of outcome and prognosis in 34 patients. Medicine (Baltimore) 1987, 66: 126-137.","journal-title":"Medicine (Baltimore)"},{"issue":"35","key":"ref_16","first-page":"698","article-title":"Infections, antibody response and gamma globulin components in multiple myeloma and macroglobulinaemia","volume":"1963","author":"Fahey, J.L.; Scoggins, R.; Utz, J.P.","unstructured":"Fahey, J.L., Scoggins, R., Utz, J.P. et al. Infections, antibody response and gamma globulin components in multiple myeloma and macroglobulinaemia. Am J Med 1963, 35: 698-707.","journal-title":"Am J Med"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/archinte.1973.03650100076014","article-title":"Infections complicating multiple myeloma and chronic lymphocytic leukaemia","volume":"132","author":"Twomey, J.T.","year":"1973","unstructured":"Twomey, J.T. Infections complicating multiple myeloma and chronic lymphocytic leukaemia. Arch Int Med 1973, 132: 562-565.","journal-title":"Arch Int Med"},{"key":"ref_18","article-title":"CAPD in end stage renal failure due to myeloma","author":"Tam, F.; Russel, G.I.; Smith, B.A.; Walls, J.","year":"1987","unstructured":"Tam, F., Russel, G.I., Smith, B.A. & Walls, J. CAPD in end stage renal failure due to myeloma. Abstract Proceedings International Society of Nephrology 1987, 201.","journal-title":"Abstract Proceedings International Society of Nephrology"},{"issue":"84","key":"ref_19","first-page":"242","article-title":"Herpes zoster and malignancy","volume":"1961","author":"Wright, E.T.; Winer, L.; Hills, B.","unstructured":"Wright, E.T., Winer, L. & Hills, B. Herpes zoster and malignancy. Arch Dermatol 1961, 84: 242-244.","journal-title":"Arch Dermatol"},{"issue":"135","key":"ref_20","first-page":"177","article-title":"Managing the complications ofplasma cell myeloma","volume":"1975","author":"Cohen, H.J.; Randle, R.W.","unstructured":"Cohen, H.J. & Randle, R.W. Managing the complications ofplasma cell myeloma. Arch Intern Med 1975,135: 177-184.","journal-title":"Arch Intern Med"},{"key":"ref_21","first-page":"172","article-title":"Multicentre study on outcomne of treatment in patients in continuous ambulatory peritoneal dialysis and haemodialysis","volume":"2","author":"Gokal, R.; Baillard, R.; Bogle, S.","year":"1987","unstructured":"Gokal, R., Baillard, R., Bogle, S. et al. Multicentre study on outcomne of treatment in patients in continuous ambulatory peritoneal dialysis and haemodialysis. Nephrol Dial Transplant 1987, 2: 172-178.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJM197912063012304","article-title":"Dialytic therapy for irreversible uremia","volume":"301","author":"Manis, T.; Friedman, E.A.","year":"1979","unstructured":"Manis, T. & Friedman, E.A. Dialytic therapy for irreversible uremia. N Engl J Med 1979, 301: 1260-1265.","journal-title":"N Engl J Med"},{"key":"ref_23","article-title":"The cost of treating end stage renal failure. Draft paper for DHSS, Elephant and","author":"Mancini, P.V.","year":"1984","unstructured":"Mancini, P.V. The cost of treating end stage renal failure. Draft paper for DHSS, Elephant and Castle, London. June 1984."},{"key":"ref_24","first-page":"89","article-title":"CAPD on Merseyside - cost effectiveness","volume":"14","author":"Beardsworth, S.F.; Goldsmith, H.J.","year":"1982","unstructured":"Beardsworth, S.F. & Goldsmith, H.J. CAPD on Merseyside - cost effectiveness. Health Trends 1982, 14: 89-91.","journal-title":"Health Trends"},{"key":"ref_25","first-page":"842","article-title":"A clinical staging system for multiple myeloma","volume":"36","author":"Durie, B.G.M.; Salmon, S.E.","year":"1975","unstructured":"Durie, B.G.M. & Salmon, S.E. A clinical staging system for multiple myeloma. Cancer 1975, 36: 842-854.","journal-title":"Cancer"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/65\/763\/302\/50076458\/postgradmedj-65-302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/65\/763\/302\/50076458\/postgradmedj-65-302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T10:31:49Z","timestamp":1683196309000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/65\/763\/302\/7044390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,5,1]]},"references-count":25,"journal-issue":{"issue":"763","published-online":{"date-parts":[[1989,5,1]]},"published-print":{"date-parts":[[1989,5,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.65.763.302","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1989,5]]},"published":{"date-parts":[[1989,5,1]]}}}